Venous venous extracorporeal membrane pulmonary oxygenation for the treatment of severe pneumonia caused by yersinia pneumocystis: a case report

YU Zhongkai; LIU Ru

doi:10.13201/j.issn.1009-5918.2024.10.007

Article navigation > J Clin Emerg > 2024 > 25(10): 544-547

Next Article Previous Article

YU Zhongkai, LIU Ru. Venous venous extracorporeal membrane pulmonary oxygenation for the treatment of severe pneumonia caused by yersinia pneumocystis: a case report[J]. J Clin Emerg, 2024, 25(10): 544-547. doi: 10.13201/j.issn.1009-5918.2024.10.007

Citation:

Venous venous extracorporeal membrane pulmonary oxygenation for the treatment of severe pneumonia caused by yersinia pneumocystis: a case report

YU Zhongkai¹,
LIU Ru^1, ,

Department of Emergency, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, China

More Information

Corresponding author: LIU Ru, E-mail: crygel@qq.com

Received Date: 10 July 2024

Publish Date: 10 October 2024

Abstract

Abstract

Severe pneumonia has the characteristics of sudden onset and high mortality rate. When traditional techniques such as tracheal intubation and mechanical ventilation are difficult to improve oxygenation in patients with severe pneumonia, venous venous extracorporeal membrane pulmonary oxygenation can serve as an advanced life support technology to provide oxygenation support for patients. This article reports the clinical data of a patient with severe pneumonia caused by Pneumocystis pneumoniae treated by intravenous extracorporeal membrane oxygenation technology, for reference by peers.
- severe pneumonia /
- Yersinia pneumoniae /
- extracorporeal membrane oxygenation

FullText(HTML)

References

[1]	Niederman MS, Torres A. Severe community-acquired pneumonia[J]. Eur Respir Rev, 2022, 31(166): 220123. doi: 10.1183/16000617.0123-2022 CrossRef Google Scholar
[2]	Grasselli G, Calfee CS, Camporota L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies[J]. Intensive Care Med, 2023, 49(7): 727-759. doi: 10.1007/s00134-023-07050-7 CrossRef Google Scholar
[3]	Xie K, Guan S, Kong X, et al. Predictors of mortality in severe pneumonia patients: a systematic review and meta-analysis[J]. Systematic Reviews, 2024, 13(1): 210. doi: 10.1186/s13643-024-02621-1 CrossRef Google Scholar
[4]	高志, 孙照祝. 重症肺炎的呼吸支持治疗进展[J]. 中国医刊, 2021, 56(9): 946-948. Google Scholar
[5]	Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia [J]. J Am Soc Nephrol, 2020, 31(6): 1157-1165. doi: 10.1681/ASN.2020030276 CrossRef Google Scholar
[6]	Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU [J]. Pharmacol Ther, 2021, 217(15): 1076-1078. Google Scholar
[7]	Kim JH, Pieri M, Landoni G, et al. Venovenous ECMO treatment, outcomes and complications in adults according to large case series: A systematic review[J]. Int J Artif Organs, 2021, 44(7): 481-488. doi: 10.1177/0391398820975408 CrossRef Google Scholar
[8]	张红玲, 余愿, 陈德昌, 等. 2023年体外生命支持临床研究回顾[J]. 中华危重病急救医学, 2024, 36(2): 118-123. Google Scholar
[9]	中华心血管病杂志编辑委员会. 中国成人暴发性心肌炎诊断和治疗指南[J]. 中华心血管病杂志, 2024, 52(1): 10-33. Google Scholar
[10]	左超, 卢秀兰, 陈智, 等. 肌钙蛋白T对暴发性心肌炎患儿病情评估的效能研究[J]. 临床急诊杂志, 2022, 23(9): 670-673. Google Scholar
[11]	Ndubisi N, van Berkel V. Veno-venous extracorporeal membrane oxygenation for the treatment of respiratory compromise[J]. Indian J Thorac Cardiovasc Surg, 2023, 39(Suppl 1): 1-7. Google Scholar
[12]	Hermann M, König S, Laxar D, et al. Low-Frequency Ventilation May Facilitate Weaning in Acute Respiratory Distress Syndrome Treated with Extracorporeal Membrane Oxygenation: A Randomized Controlled Trial [J]. J Clin Med. 2024, 13(17): 5094-5099. doi: 10.3390/jcm13175094 CrossRef Google Scholar
[13]	李妍漫, 郑在勇, 姜清陆, 等. 2017-2023年全球心力衰竭研究热点及趋势分析[J]. 实用心脑肺血管病杂志, 2024, 32(1): 9-17. Google Scholar
[14]	陈凤英, 邓颖, 李燕, 等. 急性心力衰竭中国急诊管理指南[J]. 临床急诊杂志, 2022, 23(8): 519-547. Google Scholar
[15]	石慧鑫, 蒋梦媛, 邵煜涵, 等. 耶氏肺孢子菌肺炎研究进展[J]. 中国真菌学杂志, 2024, 19(2): 206-210. Google Scholar
[16]	张彩霞, 刘新年, 杜川, 等. mNGS技术和血清G试验在判断耶氏肺孢子菌感染与定植中的价值及二者相关性研究[J]. 中国全科医学, 2023, 26(11): 1355-1360. Google Scholar
[17]	Wang Y, Zhou X, Saimi M, et al. Risk factors of mortality from pneumocystis pneumonia in non-HIV patients: a meta-analysis [J]. Frontiers Public Health, 2021, 9: 680108. doi: 10.3389/fpubh.2021.680108 CrossRef Google Scholar
[18]	杨晓赞, 王丽辉, 彭丽萍, 等. 老年2型糖尿病合并侵袭性肺真菌病的研究进展[J]. 中国老年学医学, 2023, 43(16): 4087-4092. Google Scholar
[19]	姚芳, 路敏, 孔妍, 等. 耶氏肺孢子虫肺炎患者复方磺胺甲噁唑剂量调整分析[J]. 中国临床药理学杂志, 2022, 38(3): 267-269. Google Scholar
[20]	吴蔚, 肖珍, 张顺芝, 等. 复方磺胺甲噁唑片人体生物等效性研究[J]. 中南药学, 2021, 19(12): 2555-2559. Google Scholar